Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Guida

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
Blood|October 7, 2004
Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 genePaolo Ghia, Kostas Stamatopoulos, Chrysoula Belessi, et al.
Allergy|March 6, 2021
Reply to: Kow CS et al. Are severe asthma patients at higher risk of developing severe outcomes from COVID-19?Enrico Heffler, Aikaterini Detoraki, Marco Contoli, et al.
Allergy|August 2, 2020
COVID-19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatmentsEnrico Heffler, Aikaterini Detoraki, Marco Contoli, et al.
Pulmonary Pharmacology & Therapeutics|September 2, 2019
One year of mepolizumab. Efficacy and safety in real-life in ItalyDiego Bagnasco, Marco Caminati, Francesco Menzella, et al.
The Journal of Allergy and Clinical Immunology|December 20, 2015
Fcγ-receptor 3B (FCGR3B) copy number variations in patients with eosinophilic granulomatosis with polyangiitisDavide Martorana, Francesco Bonatti, Federico Alberici, et al.
Allergy|November 28, 2019
The importance of being not significant: Blood eosinophils and clinical responses do not correlate in severe asthma patients treated with mepolizumab in real lifeDiego Bagnasco, Alessandro Massolo, Marco Bonavia, et al.
Blood|September 21, 2006
Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlationsKostas Stamatopoulos, Chrysoula Belessi, Carol Moreno, et al.
Respiratory Medicine|September 12, 2020
Efficacy of Benralizumab in severe asthma in real life and focus on nasal polyposisDiego Bagnasco, Luisa Brussino, Marco Bonavia, et al.
Journal of Personalized Medicine|February 25, 2025
Dupilumab Effectiveness in Patients with Severe Allergic Asthma Non-Responsive to OmalizumabDiego Bagnasco, Benedetta Bondi, Luisa Brussino, et al.
Journal of Personalized Medicine|July 27, 2022
COPD, but Not Asthma, Is Associated with Worse Outcomes in COVID-19: Real-Life Data from Four Main Centers in Northwest ItalyStefania Nicola, Richard Borrelli, Irene Ridolfi, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Blood|October 7, 2004
Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 genePaolo Ghia, Kostas Stamatopoulos, Chrysoula Belessi, et al.
Allergy|March 6, 2021
Reply to: Kow CS et al. Are severe asthma patients at higher risk of developing severe outcomes from COVID-19?Enrico Heffler, Aikaterini Detoraki, Marco Contoli, et al.
Allergy|August 2, 2020
COVID-19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatmentsEnrico Heffler, Aikaterini Detoraki, Marco Contoli, et al.
Pulmonary Pharmacology & Therapeutics|September 2, 2019
One year of mepolizumab. Efficacy and safety in real-life in ItalyDiego Bagnasco, Marco Caminati, Francesco Menzella, et al.
The Journal of Allergy and Clinical Immunology|December 20, 2015
Fcγ-receptor 3B (FCGR3B) copy number variations in patients with eosinophilic granulomatosis with polyangiitisDavide Martorana, Francesco Bonatti, Federico Alberici, et al.
Allergy|November 28, 2019
The importance of being not significant: Blood eosinophils and clinical responses do not correlate in severe asthma patients treated with mepolizumab in real lifeDiego Bagnasco, Alessandro Massolo, Marco Bonavia, et al.
Blood|September 21, 2006
Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlationsKostas Stamatopoulos, Chrysoula Belessi, Carol Moreno, et al.
Respiratory Medicine|September 12, 2020
Efficacy of Benralizumab in severe asthma in real life and focus on nasal polyposisDiego Bagnasco, Luisa Brussino, Marco Bonavia, et al.
Journal of Personalized Medicine|February 25, 2025
Dupilumab Effectiveness in Patients with Severe Allergic Asthma Non-Responsive to OmalizumabDiego Bagnasco, Benedetta Bondi, Luisa Brussino, et al.
Journal of Personalized Medicine|July 27, 2022
COPD, but Not Asthma, Is Associated with Worse Outcomes in COVID-19: Real-Life Data from Four Main Centers in Northwest ItalyStefania Nicola, Richard Borrelli, Irene Ridolfi, et al.
Pageof 8